GB
General Biomics, Inc.
Shutdowngeneral-biomics.com
Website unreachable since Oct 29, 2026
This biotechnology company utilizes artificial intelligence to analyze gut microbiome samples from infants, identifying potential health issues before symptoms arise. By developing patentable predictive tests, the company enhances healthcare accessibility for physicians, researchers, and patients through targeted treatment plans.
- Artificial Intelligence
- Biotechnology
- Healthcare Technology
Updated 6 months ago
Funding
Raised to date
$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This biotechnology company utilizes artificial intelligence to analyze gut microbiome samples from infants, identifying potential health issues before symptoms arise. By developing patentable predictive tests, the company enhances healthcare accessibility for physicians, researchers, and patients through targeted treatment plans.